An exchange-traded fund that tracks the Nasdaq Biotechnology Index, providing exposure to a broad basket of U.S.-listed biotechnology and pharmaceutical development companies. The fund holds large and mid-cap biotech firms involved in drug discovery, clinical research, and commercialization. Investo...
6 members of Congress have disclosed 8 trades in iShares Biotechnology ETF (IBB), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-02-23 | DAVID P. JOYCE | sell | $1K – $15K |
| 2017-02-17 | DAVID P. JOYCE | sell | $1K – $15K |
| 2016-12-30 | Carlos Mr Curbelo | sell | $1K – $15K |
| 2016-12-28 | Richard L. Hanna | sell | $1K – $15K |
| 2016-05-31 | JAMES FRENCH HILL | buy | $15K – $50K |
| 2016-05-25 | Carlos Curbelo | buy | $1K – $15K |
| 2015-12-15 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2015-08-13 | DAVID P. JOYCE | buy | $1K – $15K |